Leadership

Theresa Boyle is a molecular pathologist at the Moffitt Cancer Center and the University of South Florida. She received her pathology training at the University of Colorado and Stanford University with board certification in anatomic, clinical, and molecular genetic pathology. At Moffitt, she interprets genetic results for patient care and performs lung cancer biomarker research, leading the thoracic rapid tissue donation program. She co-founded SEQUOIA with Dr. Ravindra Kolhe to foster academic collaboration amongst laboratories to validate comprehensive NGS assays, such as the Illumina TSO500 platform, harmonize reporting, and perform quality assurance with the common goal of NGS democratization and best patient care.

Dr. Ravindra Kolhe is a Leon Henri Charbonnier Endowed Chair in  Pathology at Augusta University and is the inaugural Associate Dean for translation research at the Medical College of Georgia. He also serves as the Associate Cancer Center Director for Genomics at the Georgia Cancer Center. Currently, he leads an NCI-designated translational pathology laboratory for MATCH testing which is focused on comprehensive genomic testing in oncology. He served on the Georgia Governor’s Task Force for COVID-19 and successfully led the COVID-19 screening program for the State of Georgia during the early Pandemic.  He has led several studies, focused on adapting and validating newer technologies (NGS, RNA-seq, OGM, etc) in CLIA laboratories by establishing PLA & Z-codes and reimbursement. He has authored 90+ peer-reviewed publications and serves on multiple national committees and scientific advisory boards for numerous profit and non-profit organizations.